Reports for APO-TERAZOSIN
Brand name
APO-TERAZOSIN
Company Name
APOTEX INC
|
Drug Identification Number
02234504 |
Ingredients
TERAZOSIN |
Ingredient Strength
5 MG |
ATC Code
G04CA |
ATC Descriptor
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| APO-TERAZOSIN | 100 BTL | Resolved | 2017-09-27 | 2017-10-24 | 23655 |
| APO-TERAZOSIN | 100 BTL | Resolved | 2018-01-17 | 2018-07-31 | 36353 |
| APO-TERAZOSIN | 100 BTL | Resolved | 2023-06-16 | 2024-04-02 | 195256 |
| APO-TERAZOSIN | 100 BTL | Resolved | 2024-04-12 | 2024-05-10 | 224999 |
Showing 1 to 4 of 4
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| APO-TERAZOSIN | 500 BTL | Discontinued | 2017-03-30 | 2018-02-05 | 4749 |
Showing 1 to 1 of 1